Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression

Toru Ishikawa, Takafumi Ichida, Satoshi Sugahara, Satoshi Yamagiwa, Yasunobu Matsuda, Kazuhiro Uehara, Takashi Kato, Hiroshi Miyazaki, Hitoshi Asakura

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Thrombocytopenia is one of the major complications of liver cirrhosis. Except for hypersplenism associated with portal hypertension, it is not known which abnormalities of thrombopoiesis cause thrombocytopenia. To evaluate thrombopoiesis in liver cirrhosis, we analyzed thrombopoietin (TPO) and its receptor c-Mp1 levels in cirrhotic patients. Expression of c-Mp1 on platelets and the serum level of TPO were investigated from 38 patients with various stages of liver cirrhosis by flow-cytometric analysis and enzyme-immuno assay. Samples obtained from 22 individuals without evidence of liver disease were used as controls. Neither platelet counts nor TPO levels correlated with disease progression defined by the Child-Pugh classification. c-Mp1 was constitutively expressed on the platelets of cirrhotic patients, and its expression level was reduced with disease progression defined by the Child-Pugh classification. In this study, serum TPO did not fluctuate according to the grade of cirrhosis. However, its receptor c-Mp1, which is expressed on platelets, was decreased significantly in severely cirrhotic patients with thrombocytopenia. Thus, a correlation between reduced c-Mp1 expression and the progression of liver cirrhosis was demonstrated. We conclude that, in addition to hypersplenism, the reduced expression of c-Mp1 may play a significant role in the thrombocytopenia observed in severe liver cirrhosis.

Original languageEnglish
Pages (from-to)115-121
Number of pages7
JournalHepatology Research
Volume23
Issue number2
DOIs
Publication statusPublished - 2002 Jun 1
Externally publishedYes

Fingerprint

Thrombopoietin Receptors
Liver Cirrhosis
Disease Progression
Thrombopoietin
Blood Platelets
Thrombocytopenia
Hypersplenism
Thrombopoiesis
Enzyme Assays
Portal Hypertension
Serum
Platelet Count
Liver Diseases
Fibrosis

Keywords

  • c-Mpl
  • Liver cirrhosis
  • Thrombopoietin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression. / Ishikawa, Toru; Ichida, Takafumi; Sugahara, Satoshi; Yamagiwa, Satoshi; Matsuda, Yasunobu; Uehara, Kazuhiro; Kato, Takashi; Miyazaki, Hiroshi; Asakura, Hitoshi.

In: Hepatology Research, Vol. 23, No. 2, 01.06.2002, p. 115-121.

Research output: Contribution to journalArticle

Ishikawa, Toru ; Ichida, Takafumi ; Sugahara, Satoshi ; Yamagiwa, Satoshi ; Matsuda, Yasunobu ; Uehara, Kazuhiro ; Kato, Takashi ; Miyazaki, Hiroshi ; Asakura, Hitoshi. / Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression. In: Hepatology Research. 2002 ; Vol. 23, No. 2. pp. 115-121.
@article{b992dee57937497fa32153bc6e5f7fa5,
title = "Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression",
abstract = "Thrombocytopenia is one of the major complications of liver cirrhosis. Except for hypersplenism associated with portal hypertension, it is not known which abnormalities of thrombopoiesis cause thrombocytopenia. To evaluate thrombopoiesis in liver cirrhosis, we analyzed thrombopoietin (TPO) and its receptor c-Mp1 levels in cirrhotic patients. Expression of c-Mp1 on platelets and the serum level of TPO were investigated from 38 patients with various stages of liver cirrhosis by flow-cytometric analysis and enzyme-immuno assay. Samples obtained from 22 individuals without evidence of liver disease were used as controls. Neither platelet counts nor TPO levels correlated with disease progression defined by the Child-Pugh classification. c-Mp1 was constitutively expressed on the platelets of cirrhotic patients, and its expression level was reduced with disease progression defined by the Child-Pugh classification. In this study, serum TPO did not fluctuate according to the grade of cirrhosis. However, its receptor c-Mp1, which is expressed on platelets, was decreased significantly in severely cirrhotic patients with thrombocytopenia. Thus, a correlation between reduced c-Mp1 expression and the progression of liver cirrhosis was demonstrated. We conclude that, in addition to hypersplenism, the reduced expression of c-Mp1 may play a significant role in the thrombocytopenia observed in severe liver cirrhosis.",
keywords = "c-Mpl, Liver cirrhosis, Thrombopoietin",
author = "Toru Ishikawa and Takafumi Ichida and Satoshi Sugahara and Satoshi Yamagiwa and Yasunobu Matsuda and Kazuhiro Uehara and Takashi Kato and Hiroshi Miyazaki and Hitoshi Asakura",
year = "2002",
month = "6",
day = "1",
doi = "10.1016/S1386-6346(01)00170-X",
language = "English",
volume = "23",
pages = "115--121",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression

AU - Ishikawa, Toru

AU - Ichida, Takafumi

AU - Sugahara, Satoshi

AU - Yamagiwa, Satoshi

AU - Matsuda, Yasunobu

AU - Uehara, Kazuhiro

AU - Kato, Takashi

AU - Miyazaki, Hiroshi

AU - Asakura, Hitoshi

PY - 2002/6/1

Y1 - 2002/6/1

N2 - Thrombocytopenia is one of the major complications of liver cirrhosis. Except for hypersplenism associated with portal hypertension, it is not known which abnormalities of thrombopoiesis cause thrombocytopenia. To evaluate thrombopoiesis in liver cirrhosis, we analyzed thrombopoietin (TPO) and its receptor c-Mp1 levels in cirrhotic patients. Expression of c-Mp1 on platelets and the serum level of TPO were investigated from 38 patients with various stages of liver cirrhosis by flow-cytometric analysis and enzyme-immuno assay. Samples obtained from 22 individuals without evidence of liver disease were used as controls. Neither platelet counts nor TPO levels correlated with disease progression defined by the Child-Pugh classification. c-Mp1 was constitutively expressed on the platelets of cirrhotic patients, and its expression level was reduced with disease progression defined by the Child-Pugh classification. In this study, serum TPO did not fluctuate according to the grade of cirrhosis. However, its receptor c-Mp1, which is expressed on platelets, was decreased significantly in severely cirrhotic patients with thrombocytopenia. Thus, a correlation between reduced c-Mp1 expression and the progression of liver cirrhosis was demonstrated. We conclude that, in addition to hypersplenism, the reduced expression of c-Mp1 may play a significant role in the thrombocytopenia observed in severe liver cirrhosis.

AB - Thrombocytopenia is one of the major complications of liver cirrhosis. Except for hypersplenism associated with portal hypertension, it is not known which abnormalities of thrombopoiesis cause thrombocytopenia. To evaluate thrombopoiesis in liver cirrhosis, we analyzed thrombopoietin (TPO) and its receptor c-Mp1 levels in cirrhotic patients. Expression of c-Mp1 on platelets and the serum level of TPO were investigated from 38 patients with various stages of liver cirrhosis by flow-cytometric analysis and enzyme-immuno assay. Samples obtained from 22 individuals without evidence of liver disease were used as controls. Neither platelet counts nor TPO levels correlated with disease progression defined by the Child-Pugh classification. c-Mp1 was constitutively expressed on the platelets of cirrhotic patients, and its expression level was reduced with disease progression defined by the Child-Pugh classification. In this study, serum TPO did not fluctuate according to the grade of cirrhosis. However, its receptor c-Mp1, which is expressed on platelets, was decreased significantly in severely cirrhotic patients with thrombocytopenia. Thus, a correlation between reduced c-Mp1 expression and the progression of liver cirrhosis was demonstrated. We conclude that, in addition to hypersplenism, the reduced expression of c-Mp1 may play a significant role in the thrombocytopenia observed in severe liver cirrhosis.

KW - c-Mpl

KW - Liver cirrhosis

KW - Thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=0036626927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036626927&partnerID=8YFLogxK

U2 - 10.1016/S1386-6346(01)00170-X

DO - 10.1016/S1386-6346(01)00170-X

M3 - Article

AN - SCOPUS:0036626927

VL - 23

SP - 115

EP - 121

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 2

ER -